Medicine and Dentistry
Positron Emission Tomography
100%
Sorafenib
80%
Neoplasm
50%
Estrogen Receptor
40%
Receptor Expression
30%
Breast Cancer
30%
Fluorine-18
30%
Androgen Receptor
30%
Radioactive Tracer
20%
Combination Therapy
10%
Malignant Neoplasm
10%
Biological Marker
10%
Protein Tyrosine Kinase
10%
Hepatocellular Carcinoma
10%
Drug Megadose
10%
Molecular Imaging
10%
Hormone Therapy
10%
Anticarcinogen
10%
Angiogenesis
10%
Imaging Technique
10%
Carbon 11
10%
Metastatic Carcinoma
10%
Therapeutic Drug Monitoring
10%
Differentiated Thyroid Cancer
10%
Drug Accumulation
10%
Cancer Spread
10%
FMS-Like Tyrosine Kinase 3
10%
Clear Cell Renal Cell Carcinoma
10%
Vasculotropin Receptor 2
10%
Oxygen 15
10%
16alpha Fluoroestradiol F 18
10%
Pharmacology, Toxicology and Pharmaceutical Science
Sorafenib
100%
Neoplasm
62%
Estrogen Receptor
50%
Breast Cancer
37%
Malignant Neoplasm
37%
Fluorine 18
37%
Androgen Receptor
37%
Tracer
25%
Liver Cell Carcinoma
12%
16alpha Fluoroestradiol F 18
12%
Biological Marker
12%
Protein Tyrosine Kinase
12%
Vasculotropin Receptor 2
12%
Anticarcinogen
12%
Renal Cell Carcinoma
12%
Carbon 11
12%
Oxygen 15
12%
Differentiated Thyroid Cancer
12%
Protein Kinase Fer
12%
Vasculotropin Receptor 3
12%
Vasculotropin Receptor 1
12%
Protein Kinase Inhibitor
12%
Platelet Derived Growth Factor Receptor
12%
Combination Therapy
12%
Therapeutic Drug Monitoring
12%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Positron Emission Tomography
100%
Sorafenib
80%
Estrogen Receptor
40%
Androgen Receptor
30%
Small Molecule
10%
Metabolic Pathway
10%
Quantitative Technique
10%
FMS-Like Tyrosine Kinase 3
10%
Drug Megadose
10%
Perfusion
10%
Drug Accumulation
10%
Receptor Tyrosine Kinase
10%
Tincture of Iodine
10%
Angiogenesis
10%
Protein Kinases
10%
Platelet-Derived Growth Factor Receptor
10%
VEGF Receptors
10%